INTRODUCTION
In most eukaryotic genes, the coding sequence is interrupted by introns, which are included in initially transcribed RNA but are eventually removed by a precise splicing mechanism in the nucleus during the formation of mature messenger RNA (1) . It has been suggested that introns might play a role in chromatin structure and its relationship to gene function (2) , as well as contribute to evolutionary processes through 'exon shuffling' (3) . Introns have been shown to regulate gene expression both transcriptionally and post-transcriptionally, sometimes through alternative splicing (4) . Transcriptional regulatory elements have been identified in the introns of several genes (5) (6) (7) (8) (9) (10) , and many genes have been identified which are functionally impaired with introns removed (11) (12) .
The human purine nucleoside phosphorylase (PNP) gene, approximately 7 kb in length, is interrupted by 5 introns of varying sizes (13) (14) . The PNP gene product is an enzyme (purine-nucleoside orthophosphate ribosyltransferase; EC 2.4.2.1) which catalyzes the conversion of inosine and guanosine pentosides to the free nucleobase and pentose-1-phosphate, and is ubiquitously expressed in mammalian cells and tissues (15) . The importance of PNP expression is evident in humans where it is observed that PNP-deficient individuals develop T-cell immunodeficiency (16) , an autosomal recessive disease which is fatal during the first few years of life due to overwhelming infection. PNP deficiency is considered a prototype disease for human gene therapy (17) because its symptoms are largely restricted to the lympho-hematopoietic system (16) .
Although maintenance of sufficient PNP activity in vivo is crucial to normal immunodevelopment, little is known about the regulation of PNP gene expression. We have been interested in characterizing regulatory elements in the human PNP gene which might be important to include in vectors designed for PNP expression after retroviral-mediated gene transfer into lymphohematopoietic cells (18) . In initial studies, we characterized the promoter region of the human PNP gene (19) . Recently, it has been reported that in transgenic mice the presence of introns can have a marked effect on expression of a gene product (20) (21) . Retroviral-mediated introduction of human /?-globin genes complete with introns into murine hematopoietic tissues has also been demonstrated to result in erythroid-specific expression (22) (23) (24) (25) . The relatively small size of the PNP gene makes it conducive to genetic manipulation, and here we report the construction of a series of PNP minigenes designed to determine the role of introns on PNP gene expression after transfection into cultured mammalian cells. Human PNP gene expression was evident by both enzyme and northern analyses in transfectants of all intron-containing PNP-minigene constructs, but was not detected in transfectants of an intronless PNP minigene construct. We also identified the presence of an enhancer-like element in the first intron of the PNP gene. The results indicate that introns are necessary for the generation of mature, human PNP message in transfected murine cell populations and that intron 1 sequences contribute to the regulation of transcription.
MATERIALS AND METHODS

DNA manipulations
Plasmids were maintained in Escherichia coli K-12 strain 294, and were extracted and purified as previously described (19) . Plasmids used for transient transfection analyses were banded twice on CsCl-ethidium bromide gradients. Restriction enzymes were from New England Biolabs. Bacterial alkaline phosphatase, T4 DNA ligase and the Klenow fragment of DNA polymerase I were obtained from BRL. Taq DNA polymerase (PerkinElmer/Cetus) was used for the polymerase chain reaction (PCR).
Mammalian cell culture and gene transfer Mouse NIH 3T3 tk~ (lacking thymidine kinase) cells (26) were routinely cultivated at 37°C and 5% CO2 in Dulbecco-modified Eagle medium (DMEM, Gibco)/10% newborn calf serum, 2 mM glutamine, 50 U ml" 1 penicillin and 50 fig ml" 1 streptomycin. DNA-calcium phosphate coprecipitate-mediated transfections were as previously described (27) (28) . Briefly, 5X10 5 cells were subcultured one day prior to transfection and then exposed to precipitate overnight. In transient transfection experiments with PNP constructs, the molar equivalent of 10 fig of pPNPil-5 was transfected unless otherwise specified. For CAT plasmids, the molar equivalent of 10 fig of pCAT(An) (29) was transfected. Ten ng of pHSV-106, a herpes simplex virus thymidine kinase expression plasmid (30) (BRL), was co-transfected to standardize for variation in gene transfer efficiency in all transient transfection experiments (31) . For stable transfections, PNP minigene plasmid DNA was digested to completion with Sail and then coprecipitated at a 2.5-fold molar excess with 1 fig of pFR400, a plasmid designed for expression of the murine arg22 variant, methotrexate-resistant dihydrofolate reductase (DHFR) (32) . All transfected cells were shocked with 15% glycerol (33) in phosphate-buffered saline and, after a 2-day recovery period, either subcultured into DMEM containing 0.1 fiM methotrexate (for establishment of stable transfectants) or harvested by trypsinization for enzyme analysis. Methotrexate-resistant colonies were harvested after two weeks, pooled and expanded in culture for further characterization. Extracts of PNP minigenetransfected cells were prepared by freeze-thawing 3 times in 80 fi\ 50 mM Tris pH 7.5. Crude cytoplasmic extracts were collected after centrifugation at 16,000xg for 15 min (4°C) and desalted by Bio-gel P-10 (200-400 mesh; Bio-Rad) centrifugal column cnromatography in 10 mM Tris pH 7.5. CAT plasmid-transfected cells were lysed by 3 cycles of freeze-thawing in 220 fi\ 50 mM Tris pH 7.8 and crude cytoplasmic extracts collected after centrifugation as previously described (19) .
PNP isozyme analysis Desalted cell extracts of transient or stable transfectants (15 /il) were subjected to isoelectric focusing between pH 4 and 6.5, followed by histochemical staining of the polyacrylamide gel for PNP activity as previously described (34) . Human PNP activity, identified as material which focused at pi = 6.1, was quantitated by videodensitometry (35) .
Enzyme assays PNP activity was determined in crude cell extracts using a continuous assay at 290 nm (36) (41) were used (Fig. 3A) ; a 1.5 kb Aval fragment isolated from pPNPiO, or a 356 bp PCR product (30 cycles, 1 min 94°C, 2 min 58°C, 1 min 72°C) generated from pPNPil with primers 5'-CCGGGGCAGAAA-GGTTTAGGGC-3' (sense -174 to -153 bp upstream of the PNP transcriptional start site) and 5'-GTCACAGCACC-TGCCCCT-3' (antisense, bases 35 to 52 in intron 1). Filters were washed twice at room temperature for 15 min in 6xSSPE/0.5% SDS, 4 times at 60°C for 30 min in 0.2xSSPE/0.5% SDS and then exposed to X-ray film for 1-4 days at -70°C using an intensifying screen. Autoradiographic signals were quantitated by videodensitometry (35) .
RESULTS
Transient expression of human PNP minigenes in mouse NIH 3T3 cells
Plasmids were constructed to contain the human PNP coding sequence along with various complements of introns using human PNP genomic clones (13) and cDNA (13, 42) as starting material ( ) indicated that the PNP coding sequence was intact in pPNPiO, and that the lack of PNP expression observed in pPNPiO transfectants was not due to inadvertent disruption of the PNP coding sequence in pPNPiO (14) . We also investigated the role of a 10 bp direct repeat in the 5' untranslated region (UTR) of PNP genomic sequences which was missing in the PNP cDNA clone (and in pPNPiO), but addition of this 10 bp repeat sequence to the 5' UTR of pPNPiO did not result in detectable human PNP expression (data not shown). Human PNP transient expression ( Fig. 2 ) was quantitated by videodensitometry and the results are summarized in Fig. 1 . Transfection with PNP minigenes containing either the first intron or the first two introns resulted in similar levels of human PNP activity. Transfection with pPNPil-5, the complete PNP gene, resulted in a signal about 1.5 to 2-fold higher than with pPNPil. Interestingly, transfection with pPNPi3-5, containing the last three introns, resulted in a human PNP activity level only 15% that of pPNPil, indicating that not all introns contributed equally to increased human PNP expression after transfection into NTH 3T3 cells. Internal deletion of 2.0 kb from intron 1 (pPNPilRVX) did not significantly affect the level of human PNP expression in comparison with pPNPil, indicating the presence of intron 1 sequences contributing to PNP expression in the remaining 855 bp.
Expression of human PNP activity in stable PNP minigene transfectants In order to obtain enriched cell populations and thus provide a stronger signal for subsequent molecular analyses, heterogeneous stable transfectants were established for four of the PNP minigene constructs depicted in Fig. 1 (pPNPiO, pPNPil, pPNPil-5 and pPNPi3-5). Heterogeneous transfectant populations representing many colonies were prepared (see Materials and Methods) to minimize potential effects of flanking chromosomal sequences on expression of integrated PNP minigenes in more homogeneous populations. Southern analysis was conducted to verify co-integration of PNP minigenes into drug-resistant transfectants and to quantitate integrant copy number. Integration of pPNPiO, pPNPi3-5, pPNPil and pPNPil-5 was evident by the presence of PNPhybridizing Kpnl fragments co-migrating with plasmid controls (Fig. 3B) . However, videodensitometry of PNP-hybridizing signals demonstrated significant variation in integrant copy number, as summarized in Table 1 . We also verified that pPNPiO integrants contained complete coding sequences by digesting with Aval, which cuts in the promoter and in the 3' UTR releasing a PNP-hybridizing fragment of 1.5 kb present in 10-45 copies in these two cell populations (Fig. 3C) .
Specific PNP enzyme activities were determined in cell extracts of stable PNP minigene transfectants (Table 1) . Stable pPNPiO transfectants contained no additional PNP activity over what was observed in the mouse NIH 3T3 control. Stable transfectants of the intron-containing constructs pPNPil, pPNPi3-5 and pPNPil-5 contained 3 to 10 times as much PNP activity as the parental NIH 3T3 cells. These extracts contained, in addition to homotrimers, heterotrimers consisting of different combinations of mouse and human PNP subunits identified by isozyme analysis (Fig. 4) , consistent with previous results from stable transfectants which expressed the human PNP cDNA using heterologous transcriptional regulatory elements (34) . The exclusive presence of human homotrimer and humanj-mousei heterotrimer (Fig. 4) confirmed that human PNP expression exceeded that of endogenous mouse PNP by several-fold in these cells. Stable transfectants of pPNPi3-5 contained a higher level of PNP activity in comparison to pPNPil and pPNPil-5 transfectants than that observed in transient analyses, but this was most likely due to the presence of many more integrated copies in the pPNPi3-5 transfectants than in pPNPil and pPNPil-5 transfectants (see Fig. 3B as well as Table 1 ). These results (Table 1 and Fig. 4 ) demonstrated that, like transiently transfected cells, stable transfectants of the intronless construct pPNPiO expressed no detectable human PNP activity even though these cells contained many copies of a complete human PNP coding sequence (Fig. 3) .
PNP message levels in stable PNP minigene transfectants Northern blot analysis was carried out to determine if the observed differences in human PNP enzyme activity expressed in NIH 3T3 cells transfected with different PNP minigenes was due to the accumulation of different message levels or aberrant splicing. The 356 bp PCR product used as probe contained only 11 bp of coding sequence (from exon 1) in common with the sequence of the mouse PNP message (43), and thus did not with the higher level of specific PNP enzyme activity observed in these cells (Table 1) . A lower level of PNP message was observed in pPNPil transfectant RNA, roughly proportional to the integrant copy number (Fig. 3, Table 1 ) and enzyme activity (Table 1) (Fig. 1) was subcloned into the BamHl site in pUC9 to form pUC9ilRVX. A Sail linker (NEB # 1148) was inserted into the Klenow enzyme filled BamHl site, and then Sail casettes containing the shortened intron 1 were cloned in both orientations into a Sail site upstream of a 91 bp PNP promoter in pCAT(An)C6 and a 547 bp PNP promoter in pCAT(An)C4 (19) . Similarly a Sad linker (NEB # 1044) was added to Klenow enzyme filled BamHl and Hindm sites in pUC9i 1 RVX and Sad cassettes containing the shortened intron 1 were cloned in both orientations into a Sac! site downstream of SV40 derived sequences containing the early region polyadenylation signal in pCAT(An)C4. Transient CAT levels in NTH 3T3 cells are expressed relative to the intronless parent constructs after normalizing for efficiency of gene transfer as described in Materials and Methods. Each value represents the average of three experiments.
RNA, correlating with the absence of human PNP enzyme activity in NTH 3T3 cell transfectants of the intronless minigene pPNPiO. Since expression of the different PNP minigenes resulted in production of the same mature message, differences in accumulated levels of PNP message must have been associated with differences in message biogenesis prior to and including splicing, rather than differences in the stability of mature message. We conclude that the absence of human PNP activity in pPNPiO transfectants resulted from the lack of mature PNP message generation.
An enhancer-like element in the first intron of the human PNP gene PNP enzyme assays of NIH 3T3 cells transfected with the different PNP minigene constructs indicated that intron 1 had the greatest effect on PNP expression (Figs. 1, 2) . To determine if intron 1 sequences contributed to the regulation of transcription initiation, the shortened intron 1 sequence retained in pPNPilRVX (Fig. 1 ) was excised and inserted in both orientations upstream and downstream of a CAT transcription unit containing human PNP promoter sequences to regulate initiation of transcription (Fig. 6) (19) . By inserting the intron 1 sequence upstream of a 91 bp PNP promoter in pCAT(An)C6 (19) a similar distance between potential regulatory sequences in intron 1 and the transcriptional start site was maintained since the PNP gene 5' UTR and first exon are 130 bp long (14, 19) . We also inserted the intron 1 sequence upstream of a 547 bp PNP promoter in pCAT(An)C4 because we had determined in a separate experiment that the positive effect of intron 1 was retained when the 2.2 kb 5' flanking sequence in pPNPilRVX was truncated down to a 547 bp promoter (data not shown). Transfection of these plasmids into NTH 3T3 cells resulted in a 2.5-to 4.5-fold increase in CAT activity in comparison with PNP-CAT plasmids not containing intron 1 inserts (Fig. 6) . Increased expression was observed in both orientations for all three insert positions. These results demonstrated that an enhancer-like element (44) exists in the first intron of the human PNP gene, and that regulation of transcription initiation contributes to the intron-dependence of human PNP gene expression. However, this enhancer-like sequence was not capable of overcoming the apparent requirement for splicing, since no transient PNP expression was observed in NIH 3T3 cells transfected with plasmids containing the shortened first intron inserted in either orientation upstream of a 547 bp PNP promoter to regulate expression of the intronless PNP coding sequence.
DISCUSSION
In order to assess the role of introns in human PNP gene expression, we engineered abbreviated PNP genes containing different introns, transfected these PNP minigenes into mouse NIH 3T3 cells and assayed for human PNP activity. As observed for several other eukaryotic genes (10-12,45 -46) , much lower expression (in this case undetectable) was provided by an intronless minigene (pPNPiO) in transiently or stably transfected cells while substantial expression was observed in cells transfected with minigenes containing introns. These results indicate that intronic sequences either play a role in the rate of PNP transcription initiation, the stability of nascent RNA, or the efficiency of PNP message processing and delivery to the cytoplasm.
Intron-containing genes such as those encoding thymidine kinase (47) , bovine growth hormone (48) , and bean storage protein (49) have been found not to depend on the presence of introns for expression. However, the presence of introns has been shown to increase expression of SV40 sequences (46) , mouse dihydrofolate reductase (11), ribosomal protein rpL32 (10) and several genes in maize cells (12) . Transcriptional regulatory elements have been identified in intronic sequences (5-10), contributing to the control of tissue-specific expression of 0-globin (7) and immunoglobulin (5, 6) genes. For some systems the dependence of gene expression on the presence of introns is associated with the efficiency of splicing and generation of mature message from initial transcripts (10, 46) . Regulatory interactions between promoter and intronic sequence have been reported for immunoglobulin (50) and al(I)collagen (8) , and it has been suggested that intron-dependent expression can be promoterspecific, since intron dependence is lost when a heterologous promoter is used to regulate immunoglobulin gene transcription (51) . Results presented in this paper demonstrate that introndependent PNP gene expression is at least partially due to the presence of a transcriptional regulatory element in the first intron (see Fig. 6 ). Although the relative role of splicing per se in PNP minigene expression has not been elucidated, the comparative level of PNP enzyme activity observed in transient transfections was very low for pPNPi3-5, containing the last three PNP introns (see Figs. 1 and 2 ). This could reflect a basal level of activity obtained when a PNP transcript is provided with access to the splicing machinery, while the increased level of expression observed for pPNPil results from the combination of increased efficiency of message processing as well as increased rate of transcription due to the presence of the enhancer. The inability of intron 1 enhancer-like sequences to bring about PNP expression when inserted upstream of an intronless PNP coding sequence further supports a basal requirement for splicing. The low level of PNP activity observed in pPNPi3-5 transient transfectants argues against the presence of a transcriptional regulatory element in the last three introns.
Northern analysis indicated that the initially transcribed PNP minigene messages were properly spliced and that the level of PNP enzyme activity correlated with message level in stable transfectants (Fig. 5) . Although the identity of the processed message in the different minigene transfectants makes it unlikely that there were differences in the stability of mature message, it is possible that differential stability of initially generated transcripts in the nucleus contributed to the variable levels of PNP expression observed with the different PNP minigene constructs, particularly the intronless construct pPNPiO. We did observe that PNP expression level correlated with the total intron content of the minigene constructs (with intron 1 present; compare pPNPil-2 and pPNPil-5 with pPNPil in Figs. 1 and 2) , consistent with the idea that more extensive association with the splicing machinery either protects the message from degradation or facilitates efficient delivery of the message from the nucleus to the cytoplasm.
The conclusion that introns are required for human PNP gene expression is dependent on the integrity of the PNP coding sequence in the intronless minigene pPNPiO, and we have made several observations which indicate that the PNP coding sequence in pPNPiO was intact. First, pPNPi3-5, a minigene which was expressed after transfection into NIH 3T3 cells (Figs 1,2,4 and 5), was derived from pPNPiO, verifying that the coding sequence must be intact at least through the Kpnl site in exon 3. Secondly, a low level of PNP expression (presumably facilitated by the retrovirus enhancer) was observed when an intronless transcription unit derived from pPNPiO was placed into a retrovirus and used to transduce PA317 cells (52) . Finally, we have observed a low level of expression in NIH 3T3 cells transfected with a construct in which the PNP promoter region in pPNPiO was replaced by the Rous sarcoma virus long terminal repeat (RSV-LTR), which is a very strong promoter in NIH 3T3 cells (53) . The ability of these derivative constructs to provide expression of human PNP activity with the same isoelectric point (data not shown) as PNP extracted from HeLa cells indicated that the PNP coding sequence in pPNPiO was intact.
High levels of PNP expression have been observed in fibroblasts infected with retroviral vectors in which human PNP expression is transcriptionally regulated by the Moloney murine leukemia virus (MoMLV) LTR (54, 55) . However, PNP expression at the RNA or protein level in fibroblasts has been low or undetectable when transcription of the PNP coding sequence is regulated from an internal heterologous promoter in retroviral vectors (18, 54) . This is consistent with the relatively low level of PNP expression observed for pPNPiO or for PNP cDNA expression plasmids containing an SV40 early promoter or a mouse metallothionein I promoter transfected into Chinese hamster ovary or mouse L cells, respectively (34) . We have also found expression of a murine PNP cDNA sequence to be undetectable using the SV40 early promoter (Nelson, D.M. and Mclvor, R.S., unpublished observations) while substantial murine PNP was expressed using a MoMLV-LTR-regulated retroviral vector (43) . Intron-dependent PNP expression is not limited to constructs containing the PNP promoter, since we observed a low level of transient PNP expression when the RSV-LTR was fused to an intronless PNP coding sequence but a substantial transient PNP signal when the same promoter was fused to a PNP minigene containing intron 1 (data not shown). Thus, efficient expression of an intronless PNP coding sequence has been observed only when transcriptionally regulated by the MoMLV-LTR within the context of a full length retroviral vector genome, perhaps reflecting the different processing, cytoplasmic transfer and eventual fate of retroviral RNAs as opposed to cellular mRNAs (56) . This presents a significant obstacle to the use of non-retroviral elements to regulate PNP expression after retroviral-mediated gene transfer.
Although PNP can be termed a 'housekeeping function', an enzyme of basic cellular metabolism ubiquitously expressed across a narrow range of activities in various tissues (57) , there is evidence for differential expression of human PNP during thymic development (58) , in peripheral lymphocytes (59) , and in histochemical analyses of different tissues in experimental animals (60, 61) . Phytohemagglutinin induced T-cell transformation preferentially stimulates PNP synthesis in human T-lymphocytes (62) and phorbol ester stimulation increases PNP mRNA levels in human thymocytes (63) and leukemic cell lines (64) . The identification of sequence elements which contribute to either regulated or constitutive PNP expression might be exploited for the purpose of engineering gene transfer systems optimized for expression under specially constrained conditions. Gene expression has been reported to be facilitated in transgenic animals by the presence of either natural (7, 20) or heterologous (21) introns, and expression of genes in embryonal stem cells can require introns as well (65) . Erythroid-specific expression of human /3-globin sequences after retroviral-mediated gene transfer has been facilitated by the use of intact genes, including introns which contain regulatory sequences (22) (23) (24) (25) . The use of regulatory elements from a housekeeping gene (the murine DHFR promoter) has also been explored for extending the duration of observed expression in somatic cells (fibroblasts) transplanted into recipient animals (66) . Use of intronic or flanking sequences from the PNP gene might similarly be beneficial for optimizing PNP expression after retroviral-mediated gene transfer into lympho-hematopoietic cells in vivo, a prospect which we are currently investigating.
